Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for non-alcoholic steatohepatitis
ISRCTN85774727Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Jun 2010
- Modality
- Peptides
01
Overview
Phase 2, randomised, double-blind trial in metabolic dysfunction-associated steatohepatitis (MASH) comparing Placebo control with Liraglutide (2 arms). Primary endpoint: Primary histologic response. Started Jun 2010; status: completed.
02
Drugs
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on ISRCTN85774727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85774727.